161 related articles for article (PubMed ID: 35596597)
1. Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports.
Björnsson ES; Medina-Caliz I; Andrade RJ; Lucena MI
Hepatol Commun; 2022 Aug; 6(8):1895-1909. PubMed ID: 35596597
[TBL] [Abstract][Full Text] [Related]
2. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
Andrade RJ; Aithal GP; de Boer YS; Liberal R; Gerbes A; Regev A; Terziroli Beretta-Piccoli B; Schramm C; Kleiner DE; De Martin E; Kullak-Ublick GA; Stirnimann G; Devarbhavi H; Vierling JM; Manns MP; Sebode M; Londoño MC; Avigan M; Robles-Diaz M; García-Cortes M; Atallah E; Heneghan M; Chalasani N; Trivedi PJ; Hayashi PH; Taubert R; Fontana RJ; Weber S; Oo YH; Zen Y; Licata A; Lucena MI; Mieli-Vergani G; Vergani D; Björnsson ES;
J Hepatol; 2023 Sep; 79(3):853-866. PubMed ID: 37164270
[TBL] [Abstract][Full Text] [Related]
3. Defining characteristics and long-term prognosis of drug-induced autoimmune-like hepatitis: A retrospective cohort study.
Chung Y; Morrison M; Zen Y; Heneghan MA
United European Gastroenterol J; 2024 Feb; 12(1):66-75. PubMed ID: 38041550
[TBL] [Abstract][Full Text] [Related]
4. Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.
de Boer YS; Kosinski AS; Urban TJ; Zhao Z; Long N; Chalasani N; Kleiner DE; Hoofnagle JH;
Clin Gastroenterol Hepatol; 2017 Jan; 15(1):103-112.e2. PubMed ID: 27311619
[TBL] [Abstract][Full Text] [Related]
5. Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune Hepatitis.
Weber S; Gerbes AL
Digestion; 2023; 104(3):243-248. PubMed ID: 36603570
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced liver injury with autoimmune features.
deLemos AS; Foureau DM; Jacobs C; Ahrens W; Russo MW; Bonkovsky HL
Semin Liver Dis; 2014 May; 34(2):194-204. PubMed ID: 24879983
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune-like drug-induced liver injury: a review and update for the clinician.
Stine JG; Northup PG
Expert Opin Drug Metab Toxicol; 2016 Nov; 12(11):1291-1301. PubMed ID: 27402321
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.
Björnsson E; Talwalkar J; Treeprasertsuk S; Kamath PS; Takahashi N; Sanderson S; Neuhauser M; Lindor K
Hepatology; 2010 Jun; 51(6):2040-8. PubMed ID: 20512992
[TBL] [Abstract][Full Text] [Related]
9. A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry.
Björnsson ES; Stephens C; Atallah E; Robles-Diaz M; Alvarez-Alvarez I; Gerbes A; Weber S; Stirnimann G; Kullak-Ublick G; Cortez-Pinto H; Grove JI; Lucena MI; Andrade RJ; Aithal GP
Liver Int; 2023 Jan; 43(1):115-126. PubMed ID: 35899490
[TBL] [Abstract][Full Text] [Related]
10. [COVID-19 as a trigger of autoimmune hepatitis. Case report].
Volchkova EA; Legkova KS; Topchy TB
Ter Arkh; 2022 Feb; 94(2):259-264. PubMed ID: 36286748
[TBL] [Abstract][Full Text] [Related]
11. Ornidazole-induced autoimmune hepatitis.
Ersöz G; Vardar R; Akarca US; Tekın F; Yilmaz F; Günşar F; Karasu Z
Turk J Gastroenterol; 2011 Oct; 22(5):494-9. PubMed ID: 22234756
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced autoimmune hepatitis: A minireview.
Tan CK; Ho D; Wang LM; Kumar R
World J Gastroenterol; 2022 Jun; 28(24):2654-2666. PubMed ID: 35979160
[TBL] [Abstract][Full Text] [Related]
13. Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries.
Bessone F; Ferrari A; Hernandez N; Mendizabal M; Ridruejo E; Zerega A; Tanno F; Reggiardo MV; Vorobioff J; Tanno H; Arrese M; Nunes V; Tagle M; Medina-Caliz I; Robles-Diaz M; Niu H; Alvarez-Alvarez I; Stephens C; Lucena MI; Andrade RJ
Arch Toxicol; 2023 Feb; 97(2):593-602. PubMed ID: 36416910
[TBL] [Abstract][Full Text] [Related]
14. Acute liver injury following methylprednisolone pulse therapy: 13 cases from a prospectively collected cohort.
Allgeier J; Weber S; Todorova R; Neumann J; Gerbes A
Eur J Gastroenterol Hepatol; 2022 Apr; 34(4):457-461. PubMed ID: 35230981
[TBL] [Abstract][Full Text] [Related]
15. The Epidemiology of Newly Recognized Causes of Drug-Induced Liver Injury: An Update.
Björnsson ES
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675480
[TBL] [Abstract][Full Text] [Related]
16. "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis.
Sebode M; Schulz L; Lohse AW
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28895915
[TBL] [Abstract][Full Text] [Related]
17. New Onset Autoimmune Hepatitis during Anti-Tumor Necrosis Factor-Alpha Treatment in Children.
Ricciuto A; Kamath BM; Walters TD; Frost K; Carman N; Church PC; Ling SC; Griffiths AM
J Pediatr; 2018 Mar; 194():128-135.e1. PubMed ID: 29274889
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced autoimmune-like hepatitis.
Czaja AJ
Dig Dis Sci; 2011 Apr; 56(4):958-76. PubMed ID: 21327704
[TBL] [Abstract][Full Text] [Related]
19. [Drug-induced autoimmune-like liver injury].
Weber S
Inn Med (Heidelb); 2024 Apr; 65(4):334-339. PubMed ID: 38374310
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases.
Rodrigues S; Lopes S; Magro F; Cardoso H; Horta e Vale AM; Marques M; Mariz E; Bernardes M; Lopes J; Carneiro F; Macedo G
World J Gastroenterol; 2015 Jun; 21(24):7584-8. PubMed ID: 26140007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]